Maruo Calcium Co., Ltd. (4102) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Maruo Calcium Co., Ltd. has changed its score on 28 Nov 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROE of 1.90%

The company has been able to generate a Return on Equity (avg) of 1.90% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 1.59% and Operating profit at -48.54% over the last 5 years

The company has declared Negative results for the last 4 consecutive quarters

With ROE of 1.61%, it has a very attractive valuation with a 0.32 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Specialty Chemicals

Market cap

JPY 3,194 Million (Micro Cap)

P/E

20.00

Industry P/E

Dividend Yield

0.04%

Debt Equity

0.01

Return on Equity

1.03%

Price to Book

0.33

Revenue and Profits:

Net Sales:

2,991 Million

(Quarterly Results - Jun 2025)

Net Profit:

1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

4.32%

6 Months

2.19%

1 Year

5.65%

2 Years

4.55%

3 Years

9.96%

4 Years

11.36%

5 Years

0.5%

Maruo Calcium Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Maruo Calcium Co. Sees Valuation Upgrade Amid Mixed Financial Performance Indicators

Maruo Calcium Co., Ltd. has experienced a recent adjustment in its valuation grade, reflecting changes in its financial metrics. Key indicators include a P/E ratio of 20 and a price-to-book value of 0.32, while challenges in management efficiency and modest growth in net sales persist.

Maruo Calcium Co. Faces Valuation Shift Amidst Financial Challenges and Market Dynamics

Maruo Calcium Co., Ltd. has recently experienced a change in its evaluation, reflecting a shift in valuation metrics. The company's financial indicators, including its P/E ratio and operational efficiency measures, highlight challenges in generating shareholder value amid declining net sales growth and operating profit contraction.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

1.59%

EBIT Growth (5y)

-48.54%

EBIT to Interest (avg)

15.53

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.01

Sales to Capital Employed (avg)

1.05

Tax Ratio

35.16%

Dividend Payout Ratio

44.43%

Pledged Shares

Institutional Holding

ROCE (avg)

1.14%

ROE (avg)

1.90%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.32

EV to EBIT

748.07

EV to EBITDA

5.89

EV to Capital Employed

0.32

EV to Sales

0.24

PEG Ratio

Dividend Yield

0.04%

ROCE (Latest)

0.04%

ROE (Latest)

1.61%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.44% vs -12.24% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -96.92% vs -16.21% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,990.60",
          "val2": "2,977.50",
          "chgp": "0.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "86.60",
          "val2": "95.40",
          "chgp": "-9.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "3.90",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.40",
          "val2": "45.50",
          "chgp": "-96.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12.20%",
          "val2": "-14.60%",
          "chgp": "0.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.35% vs 2.34% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -21.75% vs 96.74% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12,843.40",
          "val2": "12,889.00",
          "chgp": "-0.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "524.50",
          "val2": "632.40",
          "chgp": "-17.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.80",
          "val2": "6.30",
          "chgp": "134.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "22.20",
          "val2": "0.30",
          "chgp": "7,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "169.80",
          "val2": "217.00",
          "chgp": "-21.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.30%",
          "val2": "10.50%",
          "chgp": "-1.02%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

2,990.60

2,977.50

0.44%

Operating Profit (PBDIT) excl Other Income

86.60

95.40

-9.22%

Interest

3.90

Exceptional Items

0.00

Consolidate Net Profit

1.40

45.50

-96.92%

Operating Profit Margin (Excl OI)

-12.20%

-14.60%

0.24%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.44% vs -12.24% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -96.92% vs -16.21% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

12,843.40

12,889.00

-0.35%

Operating Profit (PBDIT) excl Other Income

524.50

632.40

-17.06%

Interest

14.80

6.30

134.92%

Exceptional Items

22.20

0.30

7,300.00%

Consolidate Net Profit

169.80

217.00

-21.75%

Operating Profit Margin (Excl OI)

0.30%

10.50%

-1.02%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -0.35% vs 2.34% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -21.75% vs 96.74% in Mar 2024

All Annual Results

Company CV

About Maruo Calcium Co., Ltd.

Maruo Calcium Co., Ltd.

Specialty Chemicals

No Details Available.

Company Coordinates

No Company Details Available

Maruo Calcium Co., Ltd.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Poor Management Efficiency with a low ROE of 1.90%

Poor long term growth as Net Sales has grown by an annual rate of 1.59% and Operating profit at -48.54% over the last 5 years

The company has declared Negative results for the last 4 consecutive quarters

With ROE of 1.61%, it has a very attractive valuation with a 0.32 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Maruo Calcium Co. Sees Valuation Upgrade Amid Mixed Financial Performance Indicators

Maruo Calcium Co. Faces Valuation Shift Amidst Financial Challenges and Market Dynamics

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Mar'25

About Maruo Calcium Co., Ltd.

Company Coordinates